Clinical Trial Update: Development of NIC5-15 in the Treatment of Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial of NIC5-15 for Alzheimer's disease has completed, with results posted in January 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• NIC5-15

Snippet

Sponsor: VA Office of Research and Development | Conditions: Alzheimer Disease, Dementia | Phase 2 | Status: COMPLETED | Results posted: 2017-01-09